Key result
High angio-based microvascular resistance was associated with a higher risk of major adverse cardiac and cerebral events compared to low AMR in STEMI patients.
Why the study?
Does angio-based microvascular resistance (AMR) predict major adverse cardiac and cerebral events in STEMI patients after primary PCI?
Cohort (n=70)
Blinded assessors
No
Does angio-based microvascular resistance (AMR) predict major adverse cardiac and cerebral events in STEMI patients after primary PCI?
Answers are grounded in this paper and cite their sources.
Angio-based microvascular resistance (AMR) derived from a single angiographic view is a reliable, wire-free tool for estimating microvascular resistance and predicting long-term MACCEs in STEMI patients after primary PCI.
BACKGROUND: Angio-based microvascular resistance (AMR) was proposed as a tool to quantitatively assess coronary microvascular based on single angiographic projection. The aims of this study are to assess the diagnostic accuracy and prognostic significance of AMR in ST-segment elevation myocardial infarction (STEMI) patients. METHODS: AMR was measured (Of these, 22 patients measured index of microvascular resistance (IMR)) in 70 STEMI patients after primary percutaneous coronary intervention (pPCI). ST-segment resolution (STR) was assessed 2 h after pPCI simultaneously. Transthoracic echocardiography was performed within 1 day and approximately 1 year after pPCI. STEMI patients underwent pPCI were followed up for 7.3 years and the primary endpoint was the major adverse cardiac and cerebral events (MACCEs). RESULTS: AMR showed significant correlations with IMR (R = 0.334, P = 0.005). AMR has good predictive power for STR after pPCI (area under the curve: 0.889, sensitivity: 94.59%, specificity: 75.76%) in receiver operating characteristic (ROC) curve. Low-AMR patients showed markedly improved left ventricular ejection fraction (LVEF) 1 year after pPCI (42(40-49) vs. 41(39-44), P = 0.041). High-AMR patients showed higher risk for MACCEs than those with Low-AMR (HR = 3.90, P = 0.02). In multivariate cox regression analysis, AMR was considered an independent predictor of MACCEs (HR: 1.153, P = 0.020). CONCLUSIONS: AMR is a reliable tool for the estimation of microvascular resistance and prognosis in the absence of intracoronary pressure-temperature sensor wire and adenosine based on single angiographic projection.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=70). High angio-based microvascular resistance (AMR > 2.21) vs. Low angio-based microvascular resistance (AMR ≤ 2.21) was evaluated on Major adverse cardiac and cerebral events (MACCEs) (HR 3.90, 95% CI 1.23-12.31, p=0.02). High angio-based microvascular resistance was associated with a higher risk of major adverse cardiac and cerebral events compared to low AMR in STEMI patients.
Synapse has enriched 10 related papers. Consider them for comparative context: